References
- DEFACTUM. Outpatient parenteral antibiotic therapy – a health technology assessment; 2021 [cited 2022 Jul 15]. Available from: https://www.defactum.dk/Api/CfkPage/Download/?fileId=764
- Jungersen DR. Intravenøs antibiotikabehandling i eget hjem er både kompleks og supernemt. Weekly Journal for Physicians. 2022 Jan 11 [cited 2022 Jun 1]. Available from: https://ugeskriftet.dk/nyhed/intravenos-antibiotikabehandling-i-eget-hjem-er-bade-kompleks-og-supernemt
- O’Kane MJ. Patient self-testing in chronic disease management. J Lab Med. 2020;44(2):81–87.
- Kur DK, Agersnap N, Hollander NH, et al. Evaluation of the HemoCue WBC DIFF in leukopenic patient samples. Int J Lab Hematol. 2020;42(3):256–262.
- Karawajczyk M, Haile S, Grabski M, et al. The HemoCue WBC DIFF system could be used for leucocyte and neutrophil counts but not for full differential counts. Acta Paediatr. 2017;106(6):974–978.
- Hernandez-Bou S, Trenchs V, Vanegas MI, et al. Evaluation of the bedside QuickRead go(R) CRP test in the management of febrile infants at the emergency department. Eur J Clin Microbiol Infect Dis. 2017;36(7):1205–1211.
- Matheeussen V, Van Hoof V, Loens K, et al. Analytical performance of a platform for point-of-care CRP testing in adults consulting for lower respiratory tract infection in primary care. Eur J Clin Microbiol Infect Dis. 2018;37(7):1319–1323.
- Lindberg S, Jönsson I, Nilsson M, et al. A novel technology for 5-part differentiation of leukocytes point-of-Care. Point of Care. 2014;13(2):27–30.
- National Institute for Health and Care Excellence. QuickRead go for C-reactive protein testing in primary care; 2016 [cited 2022 Jun 1]. Available from: https://www.nice.org.uk/advice/mib78/resources/QuickRead-go-for-creactive-protein-testing-in-primary-care-pdf-63499354178245
- Sysmex. Sysmex XN-1000™ hematology analyzer; 2022 [cited 2022 Aug 9]. Available from: https://www.sysmex.com/US/en/products/hematology/xnseries/pages/xn-1000-hematology-analyzer.aspx
- Siemens Healthcare. Dimension Vista 1500 Intelligent Lab System; 2022 [cited 2022 Aug 9]. Available from: https://www.siemens-healthineers.com/dk/integrated-chemistry/systems/dimension-vista-1500-intel-lab-sys
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Otto Mattsson T, Lindhart CL, Schöley J, et al. Patient self-testing of white blood cell count and differentiation: a study of feasibility and measurement performance in a population of danish cancer patients. Eur J Cancer Care. 2019;29(1):e13189.
- Bui HN, Bogers JP, Cohen D, et al. Evaluation of the performance of a point-of-care method for total and differential white blood cell count in clozapine users. Int J Lab Hematol. 2016;38(6):703–709.
- Spaeth BA, Shephard MD, McCormack B, et al. Evaluation of HemoCue white blood cell differential counter at a remote health centre in australia’s Northern Territory. Pathology. 2015;47(1):91–95.
- Lohman AC, Van Rijn I, Lindhardt CL, et al. Preliminary results from a prospective study comparing white blood cell and neutrophil counts from a laboratory to those measured with a new device in patients with breast cancer. In Vivo. 2018;32(5):1283–1288.
- Brouwer N, van Pelt J. Validation and evaluation of eight commercially available point of care CRP methods. Clin Chim Acta. 2015;439:195–201.
- Papaevangelou V, Papassotiriou I, Sakou I, et al. Evaluation of a quick test for C-reactive protein in a pediatric emergency department. Scand J Clin Lab Invest. 2006;66(8):717–722.
- Marcus N, Mor M, Amir L, et al. The quick-read C-reactive protein test for the prediction of bacterial gastroenteritis in the pediatric emergency department. Pediatr Emerg Care. 2007;23(9):634–637.
- Marcus N, Mor M, Amir L, et al. Validity of the quick-read C reactive protein test in the prediction of bacterial pneumonia in the pediatric emergency department. Eur J Emerg Med. 2008;15(3):158–161.
- Longtin Y, Sax H, Leape LL, et al. Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc. 2010;85(1):53–62.
- Schwappach DLB, Wernli M. Am I (un)safe here? Chemotherapy patients’ perspectives towards engaging in their safety. Qual Saf Health Care. 2010;19(5):e9.
- Scambler S, Newton P, Sinclair AJ, et al. Barriers and opportunities of empowerment as applied in diabetes settings: a focus on health care professionals’ experiences. Diabetes Res Clin Pract. 2012;97(1):e18–e22.
- Daruwalla Z, Thakkar V, Aggarwal M, et al. Patient empowerment: the role of technology. Stud Health Technol Inform. 2019;257:70–74.